75000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Comprehensive Loss
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Condensed Consolidated Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995457 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance Disclosure
link:presentationLink
link:calculationLink
link:definitionLink
995467 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION
link:presentationLink
link:calculationLink
link:definitionLink
995477 - Disclosure - PRINCIPAL ACCOUNTING POLICIES
link:presentationLink
link:calculationLink
link:definitionLink
995487 - Disclosure - SEGMENT
link:presentationLink
link:calculationLink
link:definitionLink
995497 - Disclosure - DISPOSAL OF TJBIO SHANGHAI
link:presentationLink
link:calculationLink
link:definitionLink
995507 - Disclosure - ASSET ACQUISITIONS AND STRATEGIC TRANSACTIONS
link:presentationLink
link:calculationLink
link:definitionLink
995517 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES
link:presentationLink
link:calculationLink
link:definitionLink
995527 - Disclosure - PROPERTY, EQUIPMENT AND SOFTWARE
link:presentationLink
link:calculationLink
link:definitionLink
995537 - Disclosure - LEASES
link:presentationLink
link:calculationLink
link:definitionLink
995547 - Disclosure - INVESTMENTS
link:presentationLink
link:calculationLink
link:definitionLink
995557 - Disclosure - ACCRUALS AND OTHER PAYABLES
link:presentationLink
link:calculationLink
link:definitionLink
995567 - Disclosure - Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995577 - Disclosure - INCOME TAXES
link:presentationLink
link:calculationLink
link:definitionLink
995587 - Disclosure - TREASURY SHARES
link:presentationLink
link:calculationLink
link:definitionLink
995597 - Disclosure - SHARE-BASED COMPENSATION
link:presentationLink
link:calculationLink
link:definitionLink
995607 - Disclosure - LICENSING AND COLLABORATION ARRANGEMENTS
link:presentationLink
link:calculationLink
link:definitionLink
995617 - Disclosure - OTHER INCOME, NET
link:presentationLink
link:calculationLink
link:definitionLink
995627 - Disclosure - NET LOSS PER SHARE
link:presentationLink
link:calculationLink
link:definitionLink
995637 - Disclosure - COMMITMENTS AND CONTINGENCIES
link:presentationLink
link:calculationLink
link:definitionLink
995647 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS
link:presentationLink
link:calculationLink
link:definitionLink
995657 - Disclosure - CONCENTRATION OF CREDIT RISK
link:presentationLink
link:calculationLink
link:definitionLink
995667 - Disclosure - SUBSEQUENT EVENTS
link:presentationLink
link:calculationLink
link:definitionLink
995677 - Disclosure - PRINCIPAL ACCOUNTING POLICIES (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995687 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995697 - Disclosure - PRINCIPAL ACCOUNTING POLICIES (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995707 - Disclosure - SEGMENT (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995717 - Disclosure - DISPOSAL OF TJBIO SHANGHAI (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995727 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995737 - Disclosure - PROPERTY, EQUIPMENT AND SOFTWARE (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995747 - Disclosure - LEASES (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995757 - Disclosure - INVESTMENTS (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995767 - Disclosure - ACCRUALS AND OTHER PAYABLES (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995777 - Disclosure - Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995787 - Disclosure - INCOME TAXES (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995797 - Disclosure - SHARE-BASED COMPENSATION (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995807 - Disclosure - LICENSING AND COLLABORATION ARRANGEMENTS (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995817 - Disclosure - OTHER INCOME, NET (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995827 - Disclosure - NET LOSS PER SHARE (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995837 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995847 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION - Schedule of Principal Subsidiaries (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995857 - Disclosure - SEGMENT - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995867 - Disclosure - SEGMENT - Schedule of Disaggregated Expense Information Included in the Consolidated Statements of Comprehensive Loss (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995877 - Disclosure - DISPOSAL OF TJBIO SHANGHAI - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995887 - Disclosure - DISPOSAL OF TJBIO SHANGHAI - Summary of Reconciliation Amounts of Major Classes of Loss from Operations Classified as Discontinued Operations (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995897 - Disclosure - DISPOSAL OF TJBIO SHANGHAI - Summary of Reconciliation Amounts of Major Classes of Assets and Liabilities Classified as Discontinued Operations (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995907 - Disclosure - ASSET ACQUISITIONS AND STRATEGIC TRANSACTIONS - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995917 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES - Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995927 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES - Summary of Prepayments and Other Receivables (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995937 - Disclosure - LEASES - Operating Lease Related Assets And Liabilities And Other Related Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995947 - Disclosure - LEASES - Components of Operating Lease Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995957 - Disclosure - LEASES - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995967 - Disclosure - LEASES - Operating Lease, Future Minimum Lease Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995977 - Disclosure - LEASES - Operating Lease, Future Minimum Lease Payments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995987 - Disclosure - INVESTMENTS - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995997 - Disclosure - INVESTMENTS - Summary of Estimate the Fair Value of the Put Right Using the Following Assumptions (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996007 - Disclosure - INVESTMENTS - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996017 - Disclosure - INVESTMENTS - Summary of Roll Forward of Major Level 3 Financial Assets and Financial Liability (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996027 - Disclosure - ACCRUALS AND OTHER PAYABLES - Summary of accruals and other payables (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996037 - Disclosure - ACCRUALS AND OTHER PAYABLES - Summary of accruals and other payables (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996047 - Disclosure - Other Current Liabilities - Summary of Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996057 - Disclosure - INCOME TAXES - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996067 - Disclosure - OTHER INCOME, NET (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996077 - Disclosure - NET LOSS PER SHARE - Basic and diluted net loss per share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996087 - Disclosure - NET LOSS PER SHARE - Antidilutive securities excluded from computation of earnings per share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996097 - Disclosure - GOODWILL (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996107 - Disclosure - SHORT-TERM BORROWINGS - Additional information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996117 - Disclosure - TREASURY SHARES - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996127 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996137 - Disclosure - SHARE-BASED COMPENSATION - Summary of Options Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996147 - Disclosure - SHARE-BASED COMPENSATION - Summary of Options Activity (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996157 - Disclosure - SHARE-BASED COMPENSATION - Summary of Estimated Fair Value of Stock Options Using the Black-Scholes Option Pricing Model and Valuation Model (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996167 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Non-vested RSU Activities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996177 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Non-vested RSU Activities (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996187 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Share-Based Compensation Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996187 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Share-Based Compensation Expenses (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
996197 - Disclosure - LICENSING AND COLLABORATION ARRANGEMENTS - Additional information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996207 - Disclosure - LICENSING AND COLLABORATION ARRANGEMENTS - Breakdown of licensing and collaboration revenue (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996217 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996227 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Schedule of related party transactions (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996237 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Schedule of related party balances (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996247 - Disclosure - SUBSEQUENT EVENTS (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Schedule of Related Party Transactions, by Related Party [Table]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Payments for Legal Settlements
Payments for legal settlements
Represents the information relating to 2017 Plan
Twenty Seventeen Employee Stock Option Plan [Member]
2017 Plan
Estimated volatility assumption used in fair value measurement of put right liabilities.
Fair Value Measurement Of Put Right Liabilities, Estimated volatility
Estimated volatility
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Represents information pertaining to Put Right Liabilities Series B.
Put Right Liabilities Series B [Member]
Put Right Liabilities Series B
Series C investment.
Series C Investment [Member]
Series C Investment, Equity Transfer and Shares Repurchase Transactions
Series C Investment
Operating Lease, Liability
Total lease liabilities
Operating lease liability
Operating Lease, Liability, Total
Subsidiary, Ownership Percentage, Noncontrolling Owner
Ownership percentage
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized share-based compensation
Net gain (loss) attributable to discontinued operations
Operational loss
Less: net gain from discontinued operations
Gain from discontinued operations
Summary of Other Current Liabilities
Other Current Liabilities [Table Text Block]
Stock Repurchase Program, Authorized Amount
Amount of stock repurchase
Disposal group, including discontinued operation, contract liabilities, non-current.
Disposal group, including discontinued operation, contract liabilities, non-current
Contract liabilities, non-current
Treasury stock exercise of share options and vesting of restricted share units.
Treasury Stock Exercise of Share Options And Vesting Of Restricted Share Units
Treasury stock exercise of share options and vesting of restricted share units
Treasury shares used for issuance of ordinary shares for vesting of RSUs and exercise of stock options
Commitments and Contingencies
Commitments and contingencies (Note 16)
Weighted Average Number of Shares Outstanding, Diluted
Denominator for diluted loss per share calculation-weighted average number of common shares outstanding
Weighted-average number of ordinary shares used in calculating net loss per share - diluted
Time-based Units.
Time-based Units [Member]
Time-based Units
Stock Repurchased During Period, Shares
Repurchased shares
Ordinary shares repurchased
Net gain
Equity Securities, FV-NI, Realized Gain (Loss)
Equity Securities, FV-NI, Realized Gain (Loss), Total
Disposal of investments, equity securities
Asset Acquisition [Axis]
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Share-based compensation
Minimum [Member]
Minimum
Other Liabilities, Current [Abstract]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Issuance of ordinary shares for restricted share units (shares)
Issuance of ordinary shares for restricted share units
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent [Abstract]
Non-current liabilities of discontinued operations
Investment, Name [Axis]
Fair Value, Recurring [Member]
Fair Value, Recurring
Ownership Interest Percentage
Percentage of ownership interest.
Ownership interest
Common Stock, Shares, Issued
Ordinary shares issued
Issue of shares
Segment Reporting [Line Items]
Licensing Agreement with MorphoSys.
Licensing Agreement with MorphoSys [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Options vested and exercisable
Income tax expense
Income Tax Expense (Benefit)
Income tax expenses
Income tax benefit (expense)
Income tax expense (benefit)
Tax provision
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
Total gains included in other comprehensive income
Counterparty Name [Domain]
Counterparty Name [Domain]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Related Party Transaction [Line Items]
Restricted Stock Units (RSUs) [Member]
RSUs
Restricted share units
Operating Segments [Member]
Segment
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Schedule of Stock Options Roll Forward [Table Text Block]
Summary of options activity
GIVA
GIVA [Member]
GIVA member.
Refundable Deposit Related To Tj Biopharma Preferred Shares Sale Current Liabilities
Refundable deposit related to TJ biopharma preferred shares sale current liabilities.
Refundable deposit related to TJ Biopharma preferred shares sale
Contract with Customer, Liability
Contract liabilities
Contract with Customer, Liability, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)
Number of RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease), Total
Treasury Stock, Value
Treasury Stock (3,942,189 and 5,362,497 shares as of June 30, 2026 and December 31, 2025, respectively)
Representing the upfront and milestone payments.
Upfront And Milestone Payments
Total transaction price under the agreement
Subsequent Event Type [Domain]
Consulting and secondment expenses.
Consulting And Secondment Expenses
Consulting and secondment expenses
Represents the information relating to 2021 Share Incentive Plan
Share Incentive Plan Two Thousand Twenty One [Member]
2021 Plan
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: imputed interest
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Weighted average remaining contractual term, Outstanding
Property, Plant, and Equipment [Text Block]
PROPERTY, EQUIPMENT AND SOFTWARE
Employee service share based compensation nonvested awards total compensation cost remained to be recognized.
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Remained To Be Recognized
Share-based compensation expense remained
Effect of exchange rate changes on cash and cash equivalents
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Represents the information relating to 2022 Share Incentive Plan.
Share Incentive Plan Two Thousand Twenty Two [Member]
2022 Plan
Outstanding share percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum
General and Administrative Expense
Segment administrative expenses
General and Administrative Expense, Total
Administrative expenses
Administrative expenses
Disposal Group, Including Discontinued Operation, Revenue
Revenue
Incentive Payment From Depositary Bank Current Liabilities
Incentive payment from depositary bank current liabilities.
Incentive payment from depository bank
Income Tax Authority [Axis]
Income Tax Authority [Axis]
The amount of reduction revenue in the year.
Reduction Revenue In The Year
Reduction in the year
Reduction of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill
Risk-free rate (Based on the zero-coupon U.S. Treasury bond)
Fair Value Measurements Of Put Right Liabilities Risk Free Rate
Fair value measurements of put right liabilities risk free rate.
Related and Nonrelated Parties [Domain]
Earnings Per Share, Basic
-Basic
Net loss per share attributable to NovaBridge - basic
Net loss per share - basic
TJBio Hangzhou.
TJBio Hangzhou [Member]
TJBio Hangzhou
Represents information pertaining to share price based awards.
Share Price Based Awards
Share price based awards
Accrued research and development expense current.
Accrued Research And Development Expense Current
Accrued research and development expenses
Document Period End Date
Document Period End Date
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
ACCRUALS AND OTHER PAYABLES
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Contractual term
Tabular disclosure of cash, cash equivalents and restricted cash.
Cash, Cash Equivalents and Restricted Cash [Table Text Block]
Schedule of cash, cash equivalents and restricted cash
Payments to Acquire Property, Plant, and Equipment
Purchase of property, equipment and software
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share based payment award, stock options granted exercise price
Granted
Binomial Option Pricing Model.
Binomial Option Pricing Model [Member]
Binomial Option Pricing Model
Common Stock, Shares Authorized
Ordinary shares authorized
Ordinary shares, shares authorized
Consolidated Statements of Changes in Shareholders' Equity
Payments to Third Parties
Payments to third parties.
Payments made to third parties
Represents the information relating to Imab Hangzhou.
I-Mab Hangzhou [Member]
I-Mab Hangzhou
Prepaid Expense and Other Assets, Current
Prepayments and other receivables
Total prepayments and other receivables
Discontinued Operation, Tax Effect of Discontinued Operation
Income tax expense or benefit
Income tax expense
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign currency translation
Fair Value Measurements Of Put Right Liabilities Expected Time To Change In Control
Fair value measurements of put right liabilities expected time to change in control.
Expected time to change in control (Years)
Accrued Other General And Adminstration Expenses
Accrued other general and adminstration expenses.
Accrued other administrative expenses
Schedule disclosure of ordinary shares.
Treasury Shares [Table]
Eligible future milestone payments receivable.
Eligible Future Milestone Payments Receivable
Eligible future milestone payments receivable
Debt Instrument, Interest Rate, Stated Percentage
Interest rate
Represents the information relating to Collaboration Agreement With ABL Bio.
Collaboration Agreement With ABL Bio
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate intrinsic value, Outstanding
Withholding and Value Added Taxes
Withholding and value added taxes.
Withholding and value added taxes
Stock Repurchase Program, Period in Force
Assets
Total assets
Entity Listing, Depository Receipt Ratio
Number of ordinary shares represented by one ADS
Schedule of Equity Method Investments [Line Items]
Schedule of Equity Method Investments
Goodwill
Goodwill
Disclosure of accounting policy for recent accounting pronouncements.
New Accounting Pronouncements Not Yet Adopted [Policy Text Block]
Recent accounting pronouncements
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Numbers of shares, Outstanding
Numbers of shares, Outstanding
Numbers of shares, Outstanding
Reclassification, Comparability Adjustment [Policy Text Block]
Reclassification
Stock Issued During Period, Value, Stock Options Exercised
Exercise of stock options
Prepayments for employee incentives.
Prepayments For Employee Incentives
Prepayments for employee incentives
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of share-based compensation expenses
Granted
Share based payment award, stock options granted
Granted options
Title and Position [Domain]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Operating Lease, Payments
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities
Milestone payment received.
Milestone Payment Received
Milestone payment received
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Schedule of restricted share units activities
Antidilutive Securities, Name [Domain]
Schedule of related party balances [Table Text Block].
Schedule Of Related Party Balances [Text Block]
Schedule of related party balances
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
Number of additional shares authorized
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
Assignment And Assumption Agreement [Member]
Assignment and assumption agreement.
Assignment And Assumption Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]
Licensing And Collaboration Arrangements Summarized Financial Information Disclosure
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Remainder of 2026
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price
Disposal group, including discontinued operation, gain inclusive of write-off of intangible assets.
Disposal group, including discontinued operation, gain inclusive of write-off of intangible assets
Gain recognized inclusive of write-off of intangible assets
TJ biopharma.
TJ Biopharma [Member]
TJ Biopharma [Member]
TJ Biopharma
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months
2027
Treasury Stock, Value, Acquired, Cost Method
Repurchase of shares
Proportionate share of share based compensation expenses recorded in an equity method affiliate.
Proportionate Share Of Share Based Compensation Expenses Recorded In An Equity Method Affiliate
Proportionate share of share-based compensation expenses recorded in an equity method affiliate
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted average remaining contractual term, Outstanding
Asset Acquisitions and Strategic Transactions Disclosure [Text Block]
The entire disclosure for asset acquisition and strategic transactions.
ASSET ACQUISITIONS AND STRATEGIC TRANSACTIONS
Disaggregation of Revenue [Table Text Block]
Breakdown of licensing and collaboration revenue
Segment Reporting [Table Text Block]
Schedule of Disaggregated Expense Information Included in the Consolidated Statements of Comprehensive Loss
Schedule of components of operating lease expense.
Schedule Of Components Of Operating Lease Expense
Schedule Of Components Of Operating Lease Expense
Disposal Group, Including Discontinued Operation, Liabilities, Current
Current liabilities of discontinued operations
Total current liabilities of discontinued operations
Increase (Decrease) in Operating Lease Liability
Operating lease liability, net
Lessee, Operating Leases [Text Block]
LEASES
Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current
Accruals and other payables
Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current, Total
Stockholders' Equity Attributable to Parent
Ending balance
Beginning balance
Total shareholders' equity
Treasury Stock [Member]
Treasury stock
Operating Lease Related Assets And Liabilities And Other Related Information.
Operating Lease Related Assets And Liabilities And Other Related Information [Table Text Block]
Schedule of Operating Lease Related Assets And Liabilities And Other Related Information
Other Assets, Noncurrent
Other non-current assets
Disposal group, including discontinued operation, restricted cash, noncurrent.
Disposal group, including discontinued operation, restricted cash, noncurrent
Long-term restricted cash
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Type of arrangement [Domain]
Income Tax Disclosure [Text Block]
INCOME TAXES
Income Tax Jurisdiction, Domestic State and Local [Member]
State
Additional upfront license fee.
Additional Upfront License Fee
Additional upfront license fee
Earnings Per Share [Text Block]
NET LOSS PER SHARE
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExpirePrice
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExpirePrice
Expired
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share
Net income from discontinued operations per share - diluted
Net income per share from discontinued operations - diluted
Number of Reportable Segments
Number of reportable segments
TREASURY SHARES
Basis of Accounting, Policy [Policy Text Block]
Basis of presentation
Other Liabilities Current [Line Items]
Other liabilities current.
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Effective Income Tax Rate Reconciliation [Table]
Research and Development Service Fee
Research and development service fee.
R&D service fee charged for Visara
This member represents of China merchant bank co ltd
China Merchant Bank Co Ltd [Member]
China Merchant Bank Co Ltd
Schedule of Nonvested Share Activity [Table Text Block]
Schedule of non-vested stock option activities
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Vested
Proceeds from Stock Options Exercised
Proceeds from exercise of stock options
Short-term Lease, Cost
Expense for short-term leases within 12 months
NovaBridge Oncology (BVI) Limited [Member]
NovaBridge Oncology (BVI) Limited.
NovaBridge Oncology (BVI) Limited
Geographical [Domain]
Geographical [Domain]
Gain on disposal of investments, equity securities
Equity Method Investment, Realized Gain (Loss) on Disposal
Gain on disposal of investments, equity securities
Gain on disposal of investments, equity securities
Disposal Group, Including Discontinued Operation, Assets, Noncurrent
Non-current assets of discontinued operations
Total non-current assets of discontinued operations
Statistical Measurement [Axis]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Other comprehensive income:
Number of shares issued during the period related to Exercise of warrants
Exercise Of Warrants, Shares
Exercise of warrants (in shares)
Lessee, Operating Lease, Liability, Payments, Due Year Three
2029
Additional milestone payments.
Additional Milestone Payments
Additional milestone payments
Disposal Group, Including Discontinued Operation, Costs of Goods Sold
Cost of revenues
Represents information pertaining to Put Right Liabilities Series A.
Put Right Liabilities Series A [Member]
Put Right Liabilities Series A
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
SHARE-BASED COMPENSATION
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted-average period
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Value, Issued
Issue of shares, value
Ordinary shares ($0.0001 par value, 800,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 270,740,388 shares issued as of June 30, 2026 and December 31, 2025 ; 266,798,199 and 265,377,891 outstanding as of June 30, 2026 and December 31, 2025, respectively)
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of basic and diluted net loss per shares
Property, Plant, and Equipment [Policy Text Block]
Property, equipment and software
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from disposal of property and equipment
Liabilities
Total liabilities
Foreign Currency Transaction Gain (Loss), before Tax
Foreign exchange gain
Gain (Loss), Foreign Currency Transaction, before Tax, Total
Net foreign exchange gains/(loss)
Ownership [Domain]
Disposal Groups, Including Discontinued Operations [Table Text Block]
Summary of Reconciliation Amounts of Major Classes of Loss from Operations and Assets and Liabilities Classified as Discontinued Operations
Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent
Intangible assets
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
Weighted average expected volatility
Product and Service [Axis]
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Other Liability, Related Party, Type [Extensible Enumeration]
Fair Value, Inputs, Level 3 [Member]
Level 3
Performance Stock Unit [Member]
Performance Stock Unit [Member]
Performance Stock Unit
Gain (Loss) on Disposition of Property Plant Equipment
Loss from disposal of property and equipment and software
Disposal group, including discontinued operation, other income (expense) net.
Disposal group, including discontinued operation, other income (expense) net
Other income, net
Cybersecurity Risk Role of Management [Text Block]
Equity Method Investment, Ownership Percentage
Equity method investment, ownership percentage
Equity purchase agreement percentage
Operating Expenses
Total Expenses
Total Expenses
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments
Dividends payments
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Share based payment award, vesting period
License Agreement [Member]
License Agreement.
License Agreement
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total
Comprehensive loss attributable to redeemable noncontrolling interests
Cost sharing reimbursements
Cost sharing reimbursements.
Cybersecurity Risk Management Processes Integrated [Flag]
Stock Repurchased During Period, Value
Aggregate amount repurchased
Entity incorporation country state name.
Entity Incorporation Country State Name
Place of incorporation
Continuing Operations [Member]
Continued Operations:
Performance Based Units [Member]
Performance Based Units [Member]
Performance-based Units
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
RELATED PARTY BALANCES AND TRANSACTIONS
Common stock, shares, canceled.
Common Stock, Shares, Canceled
Ordinary shares, canceled
This member represents of loan one.
Loan One [Member]
Loan One
AskGene [Member]
AskGene.
AskGene
Disposal group, including discontinued operation, research and development expense.
Disposal Group, Including Discontinued Operation, Research and Development Expense
Research and development expenses
Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]
Current liabilities of discontinued operations
Property, Plant and Equipment, Type [Axis]
Ordinary shares available for issuance.
Ordinary Shares Available for Issuance
Ordinary shares available for issuance
Disposal Group, Including Discontinued Operation, Assets
Carrying value of assets classified as held for sale
Total assets of discontinued operations
Income Tax, Policy [Policy Text Block]
Income taxes
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
Disposal group, including discontinued operation, operating lease liabilities, current.
Disposal group, including discontinued operation, operating lease liabilities, current
Operating lease liabilities, current
Fair Value Hierarchy and NAV [Axis]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk-free interest rate (per annum)
Risk-free interest rate
Represents the information relating to Imab Hangzhou
Imab Hangzhou [Member]
I-Mab Hangzhou
Operating Lease, Liability, Current
Operating lease liabilities, current
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Write off of deferred offering fees
Write off of deferred offering fees.
Segment net loss
Segment net loss
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Outstanding
Weighted average grant date fair value, Outstanding
Share Repurchase Program [Axis]
Probability of triggering event for redemption option assumption used in fair value measurement of put right liabilities.
Fair Value Measurement Of Put Right Liabilities, Probability of Triggering Event for Redemption Rate
Probability of triggering event for redemption option
Liabilities and Equity
Total liabilities and shareholders' equity
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected dividend yield
Dividend yield
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Number of shares unvested
Forfeited
Lessee, Operating Lease, Liability, Payments, Due Year Two
2028
Research and Development Expense
Research and development expense
Research and Development Expense, Total
Receipt of CRO and CMC services - recognized in research and development expenses
Research and development expenses
Document Fiscal Period Focus
Document Fiscal Period Focus
Black-Scholes Option Pricing Model.
Black-Scholes Option Pricing Model [Member]
Black-Scholes Option Pricing Model
Maximum aggregate consideration to be received upon achievement of certain regulatory and sales-based milestone events.
Maximum aggregate consideration to be received upon achievement of certain regulatory and sales-based milestone events
This member represents of loan two.
Loan Two [Member]
Loan Two
PREPAYMENTS AND OTHER RECEIVABLES
Short-Term Debt
Short-term bank borrowings
Loan borrowed
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of valuation assumptions used
Summary of estimate the fair value of the put right using the following assumptions
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Title and Position [Axis]
AffaMed Therapeutics (HK) Limited [Member]
AffaMed Therapeutics (HK) Limited.
AffaMed Therapeutics (HK) Limited
Disposal Group, Including Discontinued Operation, Interest Income
Interest income
Proceeds from Disposal of Investments in Equity Securities
Proceeds from disposal of investments in equity securities.
Proceeds from disposal of investments, equity securities
Cybersecurity Risk Board of Directors Oversight [Text Block]
Employees And Non-employee Directors.
Employees And Non-employee Directors [Member]
Employees and non-employee directors
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Ordinary Shares [Line Items]
Treasury Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Options vested and exercisable as of June 30
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net (decrease) increase in cash and cash equivalents
Use of Estimates, Policy [Policy Text Block]
Use of estimates
Class of Stock [Domain]
Accounts Payable, Current
Accounts Payable, Current, Total
Accounts Payable
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of potentially dilutive securities that have not been included in the calculation of diluted net loss per share
Other non-current assets
Increase (Decrease) in Other Noncurrent Assets
Disposal group, including discontinued operation, administrative expense.
Disposal group, including discontinued operation, administrative expense
Administrative expenses
Administrative expenses
R and D Personnel Costs
R and D personnel costs.
Employee-related expenses
Business development and related services
Payment for Business Development and Related Services
Payment for business development and related services.
Concentration Risk Disclosure [Text Block]
CONCENTRATION OF CREDIT RISK
Payment for Product Rights
Payment for product rights.
Payment for ex-China rights to VIS-101
COMMITMENTS AND CONTINGENCIES
Subsequent Event [Line Items]
Lessor, Lease, Description [Table]
Liabilities, Current [Abstract]
Current liabilities
Debt Securities, Trading, and Equity Securities, FV-NI [Table]
Amount of capital agreed to raise.
Amount of Capital Agreed to Raise
Amount agreed to raise
Investment in Series C round of financing
SHARE-BASED COMPENSATION
Bridge Health Biotech Co Ltd [Member]
Bridge Health Biotech Co., Ltd.
Bridge Health Biotech Co., Ltd [Member]
Bridge Health
Government Assistance [Policy Text Block]
Government subsidies
Estimated volatility assumption used in fair value measurement of put right liabilities.
Fair Value Measurements Of Put Right Liabilities, Estimated volatility
Estimated volatility
Disposal Group Name [Axis]
Common Stock [Member]
Ordinary share
Business combination
Business Combinations Policy [Policy Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Exercised
Schedule of Other Nonoperating Income (Expense) [Table Text Block]
Schedule of other income, net
Statistical Measurement [Domain]
Disposal Group, Including Discontinued Operation, Assets, Noncurrent [Abstract]
Non-current assets of discontinued operations
Disclosure of accounting policies for borrowings.
Borrowings Policy, [Policy Text Block]
Borrowings
Stockholders' Equity Attributable to Parent [Abstract]
Shareholders' equity
Weighted Average Number of Shares Outstanding, Basic
Denominator for basic income (loss) per share calculation-weighted average number of common shares outstanding
Weighted-average number of ordinary shares used in calculating net loss per share - basic
Income (Loss) from Continuing Operations, Per Diluted Share
Net loss from continuing operations per share - diluted
Net loss per share from continuing operations - diluted
PROPERTY, EQUIPMENT AND SOFTWARE
Assets [Abstract]
Assets
Assets:
Accounts Payable and Accrued Liabilities, Current
Accruals and other payables
Total accruals and other payables
Accruals and other payables (including amounts with related parties of $120 and $1,131, as of June 30, 2026 and December 31, 2025, respectively - Note 17)
Common stock value authorized.
Common Stock Value Authorized
Common stock value authorized
Amount of upfront license fee paid during agreements.
Upfront License Fee
Upfront license fee
Entity Central Index Key
Entity Central Index Key
No definition available.
LICENSING AND COLLABORATION ARRANGEMENTS
Antidilutive Securities [Axis]
Due to Affiliate, Current
Payable due to an affiliate (Note 19)
Other current liabilities
Total other current liabilities
Consolidation Items [Axis]
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Current Fiscal Year End Date
Current Fiscal Year End Date
Disposal Group Name [Domain]
Redeemable Noncontrolling Interest, Equity, Carrying Amount
Redeemable Noncontrolling Interest, Equity, Carrying Amount, Total
Redeemable noncontrolling interest
Carrying amount of the redeemable NCI
Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]
Current assets of discontinued operations
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding as of December 31
Outstanding as of June 30
Business Combination [Abstract]
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Earnings Per Share, Diluted
-Diluted
Net loss per share attributable to NovaBridge- diluted
Net Ioss per share - diluted
Disposal Group, Including Discontinued Operation, Intangible Assets
Carrying value of intangible assets
Operating Lease, Weighted Average Discount Rate, Percent
Weighted average discount rate
Net loss
Net loss attributable to shareholders of NovaBridge
Ownership [Axis]
Disclosure of accounting policy for value added taxes policy.
Value Added Taxes Policy [Policy Text Block]
Value-added-tax ("VAT") recoverable and surcharges
Proceeds from Sale of Short-term Investments
Proceeds from disposal of short-term and other investments
Commitments and Contingencies Disclosure [Text Block]
COMMITMENTS AND CONTINGENCIES
Adjustments to additional paid in capital warrants exercised.
Adjustments To Additional Paid In Capital Warrants Exercised
Exercise of warrants
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
Aggregate intrinsic value, Outstanding
Two thousand twenty three stock repurchase program.
Two Thousand Twenty Three Stock Repurchase Program [Member]
2023 Stock Repurchase Program
Property, Plant and Equipment, Type [Domain]
Represents information pertaining to Put Right Liabilities.
Put Right Liabilities [Member]
Put right liabilities
Cybersecurity Risk Management Third Party Engaged [Flag]
C-Bridge V Investment Holding Limited.
C Bridge V Investment Holding Limited [Member]
C-Bridge V Investment Holding Limited
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Total other comprehensive income
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss attributable to shareholders of NovaBridge
Everest Medicines Pte Ltd [Member]
Everest Medicines Pte. Ltd
Everest Medicines Pte Ltd
Income Tax Authority [Domain]
Income Tax Authority [Domain]
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]
PRINCIPAL ACTIVITIES AND ORGANIZATION
Measurement Frequency [Domain]
The entire disclosure of prepayments and other receivables.
Prepayments And Other Receivables Text Block
PREPAYMENTS AND OTHER RECEIVABLES
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Foreign currency translation adjustments, net of tax
Foreign currency translation adjustments
Equity Components [Axis]
Equity Components [Axis]
This member represents information of Shanghai Pudong Development Bank Co., Ltd.
Shanghai Pudong Development Bank Co Ltd [Member]
Shanghai Pudong Development Bank Co., Ltd
Market And Service Based Options [Member]
Market and service based options.
Market and Service-based Options
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities
TJBio Shanghai.
TJBio Shanghai [Member]
TJBio Shanghai
Collaborative Arrangement Disclosure [Text Block]
LICENSING AND COLLABORATION ARRANGEMENTS
Prepayments for insurance and other services.
Prepayments For Insurance And Other Services
Prepayments for insurance and other services
Consolidated Statements of Cash Flows
Fair Value Hierarchy and NAV [Domain]
INCOME TAXES
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of accruals and other payables
Direct Clinical Development Expenses
Direct clinical development expenses
Direct clinical development expenses
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted
Weighted average grant-date fair value
Schedule of useful life of property plant equipment [Table Text Block].
Schedule Of Useful Life Of Property Plant Equipment [Table Text Block]
Summary of Estimated Useful Lives
Increase (Decrease) in Prepaid Expense and Other Assets
Prepayments and other receivables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Payments to Acquire Additional Interest in Subsidiaries
Equity interest subscription amount
Investment
Representing the information about termination fee payable .
Termination Fee Payable
Termination fee payable
Lessor, Lease, Description [Line Items]
Equity Securities, FV-NI
Equity Securities, FV-NI, Total
Investments at fair value, equity securities
AffaMed Therapeutics [Member]
AffaMed Therapeutics.
AffaMed
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
PRINCIPAL ACCOUNTING POLICIES
Prepayments For Deferred Offering Fees
Prepayments for deferred offering fees.
Deferred offering fees
Summary of Valuation Allowance [Table Text Block]
Schedule of movements of the valuation allowance
Derivative Contract [Domain]
The percentage of transfer of outstanding equity interest.
Percentage of Transfer of Outstanding Equity Interest
Percentage of transfer of outstanding equity interest
Class of Stock [Axis]
Probability of triggering event for redemption option assumption used in fair value measurement of put right liabilities.
Fair Value Measurements Of Put Right Liabilities, Probability of Triggering Event for Redemption Rate
Probability of triggering event for redemption option
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Potentially dilutive securities that have not been included in calculation of diluted net loss per share
Counterparty Name [Axis]
Counterparty Name [Axis]
Consulting Services
Consulting services.
Consulting services
Representing the milestone payment receivable.
Milestone Payment Receivable
Milestone payment receivable
Number of Operating Segments
Number of operating segments
Series C Preferred Stock [Member]
Series C
Service Based Options [Member]
Service based options.
Service-based Options
AOCI Attributable to Parent [Member]
Accumulated other comprehensive income
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Share based payment award, number of shares available to issue
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Accruals and other payables
Other
The amount represents other income (expense).
Other Income Expenses
Other Liabilities Current [Table]
Other liabilities current.
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents
Cash and cash equivalents
Segment Reporting, Policy [Policy Text Block]
Segment information
Disposal Group, Including Discontinued Operation, Property, Plant, and Equipment, Noncurrent
Property, equipment and software
Interest Receivable
Interest receivable
Period of financial projections considered for calculating value in use using discounted cash flows.
Period of Financial Projections for Calculating Value in Use
Period of financial projections
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Forfeited
Amortization of right of use assets.
Amortization of Right of Use Assets
Amortization of right-of use assets
Other Research and Development Expense
Other research and development expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
SHARE-BASED COMPENSATION
Disposal group, including discontinued operation, prepayments and other receivables.
Disposal group, including discontinued operation, prepayments and other receivables
Prepayments and other receivables
Canceled ordinary shares.
Canceled Ordinary Shares
Canceled ordinary shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Number of options outstanding
Number of options outstanding
Number of options outstanding
Schedule Of Nonvested Restricted Stock Units Activity Line Items
Schedule Of Nonvested Restricted Stock Units Activity [Line Items]
SHARE-BASED COMPENSATION
Short-Term Debt [Line Items]
SHORT-TERM BORROWINGS
Schedule of Short-Term Debt [Table]
Other Oncology [Member]
Other oncology member.
Other oncology
Two Thousand Twenty Six Share Incentive Plan [Member]
Two Thousand Twenty Six Share Incentive Plan.
2026 Plan
GOODWILL
Research and Development Expense, Policy [Policy Text Block]
Research and development expenses
Document Type
Document Type
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and cash equivalents
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows from operating activities
Disposal Group, Including Discontinued Operations [Line Items]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Liabilities and Equity [Abstract]
Liabilities and shareholders' equity
Schedule of Equity Method Investments [Table]
Represents information pertaining to special awards, which an be issued in the form of restricted share unit to eligible grantees that the board of the Group or a committee that board delegated its powers or authority determined appropriate with immediate effect of being fully vested.
Special Awards [Member]
Restricted share unit, special awards
Employee Stock Option
Subsequent Event
Operating Income (Loss)
Loss from operations
Operating losses
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Granted
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Lender Name [Axis]
Schedule of Indefinite-Lived Intangible Assets [Table]
Represents the information relating to I-Mab Shanghai.
I Mab Shanghai [Member]
I-Mab Shanghai
Disposal Group Classification [Axis]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Represents the information relating to Licensing Agreement with MacroGenics.
Licensing Agreement with MacroGenics
Licensing Agreement with MacroGenics [Member]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Segment Reporting [Table]
Asset Class [Domain]
Entity File Number
Entity File Number
Other Income and Other Expense Disclosure [Text Block]
OTHER INCOME, NET
U.S. Federal
Income Tax Jurisdiction, Domestic Federal [Member]
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Issuance of ordinary shares for restricted share units
Schedule of Lessee, Operating Lease, Liability, Maturity
Schedule of Lessee, Operating Lease, Future Minimum Lease Payments
Operating Activities [Domain]
Location, Statement of Income, Balance [Axis]
Reimbursement of upfront licensing payment for rights to develop VIS-101 in Asian Territories
Reimbursement of Upfront Licensing Payment
Reimbursement of upfront licensing payment.
Long-Lived Asset, Excluding Intangible Asset and Goodwill, Impairment and Disposal [Policy Text Block]
Impairment of long-lived assets
Accumulated deficit
Accumulated deficit
Investment in Debt and Equity Securities and Other Trading Assets [Text Block]
INVESTMENTS
Loan term
Debt Instrument, Term
Ferring International Center SA.
Ferring International Center SA [Member]
Ferring
Entity Registrant Name
Entity Registrant Name
PRINCIPAL ACCOUNTING POLICIES
Depreciation
Depreciation of property, equipment and software
The amount of recognition revenue in the year.
Recognition Revenue In The Year
Recognition in the year
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Net loss
Discontinued Operations [Member]
Segment Discontinued Operations
Discontinued Operations
OncoArc GmbH [Member]
OncoArc GmbH.
OncoArc GmbH
The amount Payables for purchase of property, equipment and software in non cash activities.
Payables For Purchase Of Property Equipment And Software
Payables for purchase of property, equipment and software
Entity Address, Address Line One
Entity Address, Address Line One
Other Receivables
Prepayments and other receivables
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
DISPOSAL OF TJBIO SHANGHAI
Net Income (Loss) Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net loss attributable to noncontrolling interests
Bridge Health acquisition cost
Acquisition cost liability current
Acquisition cost liability current.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Exercise of stock options (in shares)
Exercise of stock options (Shares)
Exercised
Discontinued Operations:
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Spot price assumption used in fair value measurement of put right liabilities.
Fair Value Measurement Of Put Right Liabilities, Spot Price
Spot price
Other Receivable, after Allowance for Credit Loss, Related Party, Type [Extensible Enumeration]
Assets, Current
Current assets
Total current assets
2024 Share Incentive Plan.
Two Thousand and Twenty Four Share Incentive Plan [Member]
2024 Plan
Income Tax Jurisdiction, Foreign [Member]
Non-U.S.
Investment Accounted For Using The Equity Method And Put Right Liabilities Abstract
INVESTMENTS ACCOUNTED FOR USING THE EQUITY METHOD AND PUT RIGHT LIABILITIES
Fair Value, Recurring and Nonrecurring [Table]
Equity Securities, FV-NI, Noncurrent
Investments at fair value, equity securities
Earnings Per Share, Policy [Policy Text Block]
Loss per share
Condensed Income Statement [Table]
Segments [Axis]
Short-Term Debt, Lender
Lender name
Supplemental Cash Flow Information [Abstract]
Additional ASC 842 supplemental disclosures
Assets held for sale.
Assets Held for Sale [Member]
Related Party Transactions Disclosure [Text Block]
RELATED PARTY BALANCES AND TRANSACTIONS
Representing the payments related to withholding tax amount
Payments Related To Withholding Tax Amount
Investment, Name [Domain]
Disposal group, including discontinued operation, equity in income (loss) of affiliate.
Disposal group, including discontinued operation, equity in income (loss) of affiliate
Equity in loss of affiliate
Foreign Currency Transaction Gain, before Tax
Foreign exchange gain
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Forfeited
Significant Accounting Policies [Text Block]
PRINCIPAL ACCOUNTING POLICIES
NovaBridge Biosciences Shanghai Co Ltd [Member]
NovaBridge Biosciences Shanghai Co Ltd.
NovaBridge Biosciences (Shanghai) Co. Ltd.
Consolidation Items [Domain]
Other Assets
Other receivables
Employee-related Liabilities, Current
Employee salary and benefits
Treasury Stock, Shares, Acquired
Repurchase of shares (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Intangible assets
Spot price assumption used in fair value measurement of put right liabilities.
Fair Value Measurements Of Put Right Liabilities, Spot Price
Spot price
NET LOSS PER SHARE
Net loss per share attributable to shareholders
Disclosure of accounting policy for short-term investments.
Short Term Investments [Policy Text Block]
Short-term investments
Lessee, Operating Lease, Liability, Payments, Due Year Four
2030
Ordinary shares surrendered by A shareholder shares.
Ordinary Shares Surrendered By A Shareholder Shares
Ordinary shares surrendered by a shareholder
Effective Income Tax Rate Reconciliation [Line Items]
Disclosure of accounting policy for restricted cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Restricted cash
Plan Name [Axis]
Plan Name [Axis]
Subsequent Event Type [Axis]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total
Unrecognized tax benefits, interest and penalties recognized
Disclosure of accounting policy for long term investments.
Long Term Investments [Policy Text Block]
Long-term investments
Product and Service [Domain]
NovaBridge [Member]
Novabridge member.
NovaBridge
Stockholders' Equity Note Disclosure [Text Block]
TREASURY SHARES
Expected term assumption used in fair value measurement of put right liabilities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Fair Value Measurement Of Put Right Liabilities, Expected Terms
Expected terms (Year)
Measurement Frequency [Axis]
PRC.
PRC [Member]
PRC
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities
Line of Credit Facility, Lender [Domain]
Entity Incorporation, Date of Incorporation
Date of incorporation or acquisition
Interest Payable
Interest payable
Liabilities [Abstract]
Liabilities
Liabilities
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent
Other non-current assets
Office and laboratory space.
Office and Laboratory Space [Member]
Office and Laboratory Space
Treasury Stock, Common, Shares
Treasury stock not in use and not outstanding
Ending balance (in shares)
Beginning balance (in shares)
Treasury stock, shares
Impairment loss on goodwill
Impairment of goodwill
Impairment of goodwill
Derivative Instrument [Axis]
Equity Component [Domain]
Equity Component [Domain]
Operating Activities [Axis]
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive loss
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax
Gain from sale
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Total
Gain on sale of discontinued operations
Entity Address, City or Town
Entity Address, City or Town
Business Acquisition [Axis]
Payments to Acquire Short-Term Investments
Purchase of short-term and other investments
Disposal group, including discontinued operation, operating lease right of use assets, noncurrent.
Disposal group, including discontinued operation, operating lease right of use assets, noncurrent
Operating lease right-of-use assets
Segments [Domain]
Visara [Member]
Visara member.
Visara
Net Income (Loss) Attributable to Parent [Abstract]
Numerator:
Fair value of Level 3 financial liabilities / assets at the beginning of the period
Fair value of Level 3 financial liabilities / assets at the beginning of the period
Fair value of Level 3 financial liabilities / assets at the end of the period
Fair Value, Net Asset (Liability) Measured on Recurring Basis with Unobservable Inputs
Fair value, net asset (liability) measured on recurring basis with unobservable inputs.
Increase (Decrease) in Other Noncurrent Liabilities
Other non-current liabilities
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Denominator:
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Share Based Compensation Arrangement By Share Based Payment Award Options Expiration In Period.
Share Based Compensation Arrangement By Share Based Payment Award Options Expiration In Period
Expired
Description of principal subsidiaries activities.
Description of principal subsidiaries activities
Principal activities
Accrued legal expenses current.
Accrued Legal Expenses Current
Accrued legal expenses
Proceeds from License Fees Received
Proceeds from milestone achievement
Fair Value Measurements Of Put Right Liabilities Equity Market Adjustment
Fair value measurements of put right liabilities equity market adjustment.
Equity market adjustment
Statement [Table]
Statement [Table]
Lease, Cost
Operating lease expense
Total operating lease rental expense
Share-based Payment Arrangement, Expense
Share-based compensation expense
Share-based compensation expenses
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Loss before income tax
Loss from continuing operations before income tax expense
Loss before income tax expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Time to maturity (in years)
Weighted average expected term (years)
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash generated from investing activities
OTHER INCOME, NET
Statement [Line Items]
INCOME TAXES
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
PRINCIPAL ACCOUNTING POLICIES
Lessor, Operating Lease, Term of Contract
Sublease term
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share, Total
Net income from discontinued operations per share - basic
Net income per share from discontinued operations - basic
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested
Number of shares vested
Disposal group, including discontinued operation, short-term bank borrowings, current.
Disposal group, including discontinued operation, short-term bank borrowings, current
Short-term bank borrowings
Maximum [Member]
Maximum
Schedule Of Principal Subsidiaries Table Text Block
Schedule Of Principal Subsidiaries [Table Text Block]
Schedule of Principal Subsidiaries
Schedule Of Principal Subsidiaries Table
Schedule Of Principal Subsidiaries [Table]
Total gains included in earnings
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings
ADR [Member]
ADS
ADS
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total
Unrealized gain on available-for-sale debt securities
Investment Income, Interest
Interest income, net
Share based compensation arrangement by share based payment award equity instruments other than options discontinued operation weighted average grant date fair value.
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Discontinued Operation Weighted Average Grant Date Fair Value
Weighted average grant date fair value
Disposal Groups, Including Discontinued Operations [Table]
Business Acquisition, Acquiree [Domain]
Business Acquisition, Percentage of Voting Interests Acquired
Voting Interests Acquired
Equity interests ownersip acquired
2019 Share Incentive Plan [Member].
Twenty Nineteen Share Incentive Plan [Member]
2019 Plan
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Schedule of non-vested RSU activities
Consolidation, Policy [Policy Text Block]
Basis of consolidation
Represents the information relating to 2020 Share Incentive Plan.
Twenty Eighteen Employee Stock Option Plan [Member]
2018 Plan
SUBSEQUENT EVENTS
Prepaid Supplies
Prepayments to CRO vendors
Asset Class [Axis]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of the deferred tax assets and liabilities
Investments, Debt and Equity Securities [Abstract]
License and sublicense agreement with ferring.
License And Sublicense Agreement With Ferring [Member]
License and Sublicense Agreement with Ferring
CONCENTRATION OF CREDIT RISK
Disposal group, including discontinued operation, additional gain recognized related to sale.
Disposal group, including discontinued operation, additional gain recognized related to sale
Additional gain recognized related to sale
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Granted
Assets, Current [Abstract]
Current assets
LEASES
Document Fiscal Year Focus
Document Fiscal Year Focus
Shanghai [Member]
Shanghai.
Shanghai
Common Stock, Shares, Outstanding
Ordinary shares outstanding
Common stock, shares outstanding
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
CN Member
C N [Member]
CN
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Two Thousand and Twenty Five Share Incentive Scheme [Member]
Two thousand and twenty five share incentive scheme.
2025 Share Incentive Scheme
Operating lease right of use asset non current.
Operating Lease Right Of Use Asset Non Current
Operating lease right-of-use assets, non-current
Operating lease right of use asset
ABio-X Holdings, Inc.
ABio-X Holdings, Inc. [Member]
ABio-X Holdings, Inc.
ABio-X
Consolidated Statements of Comprehensive Loss
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Aggregate intrinsic value, Options vested and exercisable
Business Combination [Line Items]
Business Combination, Consideration Transferred
Business Combination, Consideration Transferred, Total
Total consideration
Revenue from Contract with Customer [Policy Text Block]
Revenue recognition
Related Party [Member]
Related Parties
Operating Lease, Liability, Noncurrent
Operating lease liabilities, non-current
Lessee, Operating Lease, Liability, Payments, Due
Total undiscounted lease payments
Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent
Other non-current liabilities
Subsidiary, Ownership Percentage, Parent
Percentage of direct or indirect ownership by the company
Equity interests ownersip acquired
Additional Paid in Capital, Common Stock
Additional paid-in capital
C-Bridge Joint Value Creation (HK) Limited [Member]
C-Bridge Joint Value Creation (HK) Limited.
C-Bridge Joint Value Creation (HK) Limited
Revenue
Subsidy income
Revenues, Total
Revenues
Available-for-Sale Securities [Member]
Investments in available-for-sale debt securities
Related and Nonrelated Parties [Axis]
New Accounting Pronouncements, Policy [Policy Text Block]
Adopted accounting pronouncements
Warrant [Member]
Warrants
Disposal Group, Including Discontinued Operation, Assets, Current
Current assets of discontinued operations
Total current assets of discontinued operations
Disposal group, including discontinued operation, contract liabilities, current.
Disposal group, including discontinued operation, contract liabilities, current
Contract liabilities, current
Entity Address, State or Province
Prepayments to contract research organization vendors.
Prepayments to Contract Research Organization Vendors
Prepayments to CRO vendors
Total services received from related parties
Related Party Transaction, Amounts of Transaction
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Numbers of shares
Liabilities held for sale.
Liabilities Held for Sale [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Ordinary shares were available to issue
Share based payment award, maximum shares authorized
Expected term assumption used in fair value measurement of put right liabilities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Fair Value Measurements Of Put Right Liabilities, Expected Terms
Expected terms (Year)
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets
Operating lease right-of-use assets, non-current
Milestone payments for development and regulatory milestones
Milestone Payments for Development and Regulatory Milestones
Milestone payments for development and regulatory milestones.
Amendment Flag
Amendment Flag
Share-Based Payment Arrangement [Text Block]
SHARE-BASED COMPENSATION
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Sublease Income
Sublease income
Debt Instrument [Axis]
Other Nonoperating Income (Expense)
Provision of FTE and other services - recognized in other income
Other income, net
Total other income, net
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Total
Total cash and cash equivalents and restricted cash
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Incentive income from depository bank.
Incentive Income From Depository Bank
Income of incentive payment from depository bank
Represents the information relating to MorphoSysAG.
MorphoSys AG
Receivable from ABL Bio collaboration.
Receivable From ABL Bio Collaboration
Receivable from ABL Bio collaboration
Unrecognized Tax Benefits
Unrecognized Tax Benefits, Ending Balance
Unrecognized Tax Benefits, Beginning Balance
Unrecognized tax benefits
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
PRINCIPAL ACTIVITIES AND ORGANIZATION
Comprehensive Income, Policy [Policy Text Block]
Comprehensive loss
Debt Instrument, Collateral Amount
Collateral value
Research and Development Expense [Abstract]
Segment research and development expenses:
Market Based Units [Member]
Market Based Units [Member]
Market-based Units
Maximum aggregate consideration to be received upon achievement of certain regulatory and sales-based milestone events as well as royalties.
Maximum Aggregate Consideration To Be Received Upon Achievement Of Certain Regulatory And Sales-based Milestone Events As Well As Royalties
Maximum aggregate consideration to be received upon achievement of certain regulatory and sales-based milestone events as well as royalties
Visara Inc [Member]
Visara, Inc.
Visara, Inc.
Operating Expenses [Abstract]
Expenses
Due to Related Parties
Accruals and other payables
Other Liabilities, Total
Income (Loss) from Continuing Operations, Per Basic Share
Net loss from continuing operations per share - basic
Net loss per share from continuing operations - basic
Common Stock, Par or Stated Value Per Share
Ordinary shares, par value
Ordinary shares par value
Accounts Payable and Accrued Liabilities, Current [Abstract]
Current:
Predecessor Plans
Predecessor Plans [Member]
Predecessor plans.
Represents the information relating to other partners.
Other Partners [Member]
Other partners
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted average remaining contractual term, Exercisable
Indefinite-lived Intangible Assets [Line Items]
Lessee, Leases [Policy Text Block]
Leases
Share Incentive Plan Two Thousand Twenty
Share Incentive Plan Two Thousand Twenty [Member]
2020 Plan
Liabilities, Current
Current liabilities
Total current liabilities
Noncash Investing and Financing Items [Abstract]
Non-cash activities
Other Liabilities Disclosure [Text Block]
Other Current Liabilities
Schedule Of Nonvested Restricted Stock Units Activity Table
Schedule Of Nonvested Restricted Stock Units Activity [Table]
Percentage of annual net sales.
Percentage of Annual Net Sales
Percentage of annual net sales
Segment Reporting [Text Block]
SEGMENT
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Type of arrangement [Axis]
Disposal group, including discontinued operation, investments accounted for using equity method, noncurrent.
Disposal group, including discontinued operation, investments accounted for using equity method, noncurrent
Investments accounted for using the equity method
Share Repurchase Program [Domain]
VIS-101 [Member]
VIS-101.
VIS-101
Geographical [Axis]
Geographical [Axis]
Receivable from collaboration agreement.
Receivable From Collaboration Agreement
Receivable from collaboration agreement
Property, Plant, and Equipment [Table Text Block]
Schedule of property, equipment and software
Cybersecurity Risk Management, Strategy, and Governance [Table]
Fair Value Measurement, Policy [Policy Text Block]
Fair value measurements
Cybersecurity Risk Management Processes Integrated [Text Block]
Subsequent Event [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term
Weighted average remaining contractual term, Options vested and exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Number of shares granted
Granted
Additional Paid-in Capital [Member]
Additional paid-in capital
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
Summary of prepayments and other receivables
Plan Name [Domain]
Plan Name [Domain]
Disposal Group Classification [Domain]
Other Liabilities, Noncurrent
Other non-current liabilities
Greater china.
Greater China [Member]
Greater China [Member]
Business Combination [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Intrinsic value of options exercised
Due To Related Party, Other Liabilities
Due to related party, other liabilities.
Due to related parties
SHORT-TERM BORROWINGS
Cover [Abstract]
No definition available.
Other Supplemental Cash Flow Disclosures [Abstract]
Other supplemental cash flow disclosures
Write Off of Deferred Cost for Planned Dual Listing
Write-off of deferred cost for planned dual listing.
Write-off of deferred cost for planned dual listing
Segment Reporting, Other Segment Item, Amount
Other segment items
Other segment items
Represents the information relating to I-MabBiopharma US Ltd.
I-Mab Biopharma US Ltd. [Member]
I-Mab Biopharma US Ltd.
Licensing and Collaboration.
Licensing and Collaboration [Member]
Licensing and collaboration revenue
Share-based Payment Arrangement, Forfeiture [Policy Text Block]
Share-based compensation
Operating Lease, Weighted Average Remaining Lease Term
Weighted average remaining lease term (years)
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent
Non-current liabilities of discontinued operations
Total non-current liabilities of discontinued operations
Number of treasury shares exercise of option.
Treasury Stock Exercise of Option
Treasury stock exercise of option
Represents the information relating to I-Mab Biopharma Hong Kong Limited.
I-Mab Biopharma Hong Kong Limited [Member]
I-Mab Biopharma Hong Kong Limited
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of Roll Forward of Major Level 3 Financial Assets and Financial Liability
Fair value change of available-for-sale debt securities
Debt Securities, Available-for-Sale, Unrealized Gain (Loss), Total
Unrealized loss on available-for-sale debt securities
Unrealized gain on available-for-sale debt securities, net of tax
Unrealized gain on the available-for-sale investments
Unrealized gain on available-for-sale debt securities
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income
Debt and Equity Securities, FV-NI [Line Items]
NovaBridge CV Limited
NovaBridge CV Limited [Member]
NovaBridge CV Limited.
Share-based Payment Arrangement, Noncash Expense, Total
Share-based compensation
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities
Short-term Investments.
Short-term investments
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Investments in equity securities
Equity Securities [Member]
I-MabTianjini.
I-Mab Tianjin [Member]
I-Mab Tianjin
NovaBridge Oncology [Member]
NovaBridge Oncology.
NovaBridge Oncology
Disposal Group, Including Discontinued Operation, Liabilities
Carrying value of liabilities classified as held for sale
Total liabilities
Net cash generated from financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Related Party Transactions [Table Text Block]
Schedule of related party transactions
ACCRUALS AND OTHER PAYABLES
The amount of licensing and collaboration revenue.
Licensing and Collaboration Revenue
Revenues
Total licensing and collaboration revenue
The advance cash outflow to reacquire common and preferred stock.
Prepayments For Stock Repurchase
Prepayments for stock repurchase
Debt Instrument, Name [Domain]
Tasgen Group
Represents the information relating to Tasgen Group
Tasgen Group [Member]
Lessee Operating Lease Liability Payments Due After Year Four
Lessee operating lease liability payments due after year four.
Thereafter
Two Thousand Twenty Five Omnibus Share Incentive Plan [Member]
Two thousand twenty five omnibus share incentive plan [Member]
2025 Omnibus Share Incentive Plan
Represents the information relating to AbbVie.
AbbVie
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
Total net book value of property, equipment and software
Property, equipment and software
Shares, Outstanding
Ending balance (in shares)
Beginning balance (in shares)
Asset Acquisition [Domain]
Representing the amount of Milestone payments.
Milestone Payments
Milestones
Milestone payments
Segment Reporting [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of differences between the Hong Kong statutory income tax rate and the Group's effective income tax rate
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Fair value of common stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price
Consolidated Balance Sheets